Literature DB >> 11906969

The effects of neuroleptics on the GABA-induced Cl- current in rat dorsal root ganglion neurons: differences between some neuroleptics.

Kenjiro Yokota1, Hideharu Tatebayashi, Tadashi Matsuo, Takashi Shoge, Haruhiko Motomura, Toshiyuki Matsuno, Akira Fukuda, Nobutada Tashiro.   

Abstract

1. Several neuroleptics inhibited the 3 microM gamma-aminobutyric acid induced-chloride current (GABA-current) on dissociated rat dorsal root ganglion neurons in whole-cell patch-clamp investigations. 2. The IC(50) for clozapine, zotepine, olanzapine, risperidone and chlorpromazine were 6.95, 18.26, 20.30, 106.01 and 114.56 microM, respectively. The values for the inhibitory effects of neuroleptics on the GABA (3 microM)-current, which were calculated by the fitting Hill's equations where the concentrations represent the mean therapeutic blood concentrations, were ranked clozapine>zotepine>chlorpromazine>olanzapine>risperidone. These inhibitory effects, weighted with the therapeutic concentrations of neuroleptics, were correlated with the clinical incidences of seizure during treatment with neuroleptics. 3. Clozapine reduced the picrotoxin-inhibiton, and may compete with a ligand of the t-butylbicyclophosphorothionate (TBPS) binding site. 4. Haloperidol and quetiapine did not affect the peak amplitude of the GABA (3 microM)-current. However, haloperidol reduced the clozapine-inhibition, and may antagonize ligand binding to TBPS binding site. 5. Neuroleptics including haloperidol and quetiapine enhanced the desensitization of the GABA (3 microM)-current. However, haloperidol and quetiapine at 100 microM inhibited the desensitization at the beginning of application. 6. Blonanserin (AD-5423) at 30 and 50 microM potentiated the GABA (3 microM)-current to 170.1+/-6.9 and 192.0+/-10.6% of the control current, respectively. Blonanserin shifted GABA concentration-response curve leftward. Blonanserin only partly negatively interacted with diazepam. The blonanserin-potentiation was not reversed by flumazenil. Blonanserin is not a benzodiazepine receptor agonist. 7. The various effects of neuroleptics on the GABA-current may be related to the clinical effects including modifying the seizure threshold.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11906969      PMCID: PMC1573270          DOI: 10.1038/sj.bjp.0704608

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  40 in total

1.  Gabapentin prophylaxis of clozapine-induced seizures.

Authors:  S I Usiskin; R Nicolson; M Lenane; J L Rapoport
Journal:  Am J Psychiatry       Date:  2000-03       Impact factor: 18.112

2.  Determination of risperidone and 9-hydroxyrisperidone in human plasma by high-performance liquid chromatography: application to therapeutic drug monitoring in Japanese patients with schizophrenia.

Authors:  T Nagasaki; T Ohkubo; K Sugawara; N Yasui; H Furukori; S Kaneko
Journal:  J Pharm Biomed Anal       Date:  1999-03       Impact factor: 3.935

3.  Dominant GABA(A) receptor/Cl- channel kinetics correlate with the relative expressions of alpha2, alpha3, alpha5 and beta3 subunits in embryonic rat neurones.

Authors:  R Serafini; D Maric; I Maric; W Ma; J M Fritschy; L Zhang; J L Barker
Journal:  Eur J Neurosci       Date:  1998-01       Impact factor: 3.386

4.  Clozapine dose-concentration relationships in plasma, hair and sweat specimens of schizophrenic patients.

Authors:  V Cirimele; P Kintz; O Gosselin; B Ludes
Journal:  Forensic Sci Int       Date:  2000-01-10       Impact factor: 2.395

5.  Olanzapine serum concentrations in psychiatric patients given standard doses: the influence of comedication.

Authors:  O V Olesen; K Linnet
Journal:  Ther Drug Monit       Date:  1999-02       Impact factor: 3.681

6.  Phosphorylation of the GABAA receptor gamma2L subunit in rat sensory neurons may not be necessary for ethanol sensitivity.

Authors:  J Zhai; R R Stewart; M W Friedberg; C Li
Journal:  Brain Res       Date:  1998-09-14       Impact factor: 3.252

Review 7.  Effects of risperidone in overdose.

Authors:  A A Acri; F M Henretig
Journal:  Am J Emerg Med       Date:  1998-09       Impact factor: 2.469

8.  Dieldrin and picrotoxinin modulation of GABA(A) receptor single channels.

Authors:  T Ikeda; K Nagata; T Shono; T Narahashi
Journal:  Neuroreport       Date:  1998-10-05       Impact factor: 1.837

9.  Clozapine and several other antipsychotic/antidepressant drugs preferentially block the same 'core' fraction of GABA(A) receptors.

Authors:  R F Squires; E Saederup
Journal:  Neurochem Res       Date:  1998-10       Impact factor: 3.996

10.  Clozapine and olanzapine treatment decreases rat cortical and limbic GABA(A) receptors.

Authors:  D Farnbach-Pralong; R Bradbury; D Copolov; B Dean
Journal:  Eur J Pharmacol       Date:  1998-05-22       Impact factor: 4.432

View more
  5 in total

1.  Comparative analysis of the treatment of chronic antipsychotic drugs on epileptic susceptibility in genetically epilepsy-prone rats.

Authors:  Rita Citraro; Antonio Leo; Rossana Aiello; Michela Pugliese; Emilio Russo; Giovambattista De Sarro
Journal:  Neurotherapeutics       Date:  2015-01       Impact factor: 7.620

2.  Lidocaine depolarizes the mitochondrial membrane potential by intracellular alkalization in rat dorsal root ganglion neurons.

Authors:  Shin Onizuka; Tetsu Yonaha; Ryuji Tamura; Masatoshi Kasiwada; Toshiro Shirasaka; Isao Tsuneyoshi
Journal:  J Anesth       Date:  2011-01-07       Impact factor: 2.078

3.  Effects of zotepine on extracellular levels of monoamine, GABA and glutamate in rat prefrontal cortex.

Authors:  S Yamamura; K Ohoyama; T Hamaguchi; M Nakagawa; D Suzuki; T Matsumoto; E Motomura; H Tanii; T Shiroyama; M Okada
Journal:  Br J Pharmacol       Date:  2009-04-09       Impact factor: 8.739

Review 4.  Blonanserin: a review of its use in the management of schizophrenia.

Authors:  Emma D Deeks; Gillian M Keating
Journal:  CNS Drugs       Date:  2010-01       Impact factor: 5.749

5.  Tricyclic antipsychotics and antidepressants can inhibit α5-containing GABAA receptors by two distinct mechanisms.

Authors:  Konstantina Bampali; Filip Koniuszewski; Luca L Silva; Sabah Rehman; Florian D Vogel; Thomas Seidel; Petra Scholze; Florian Zirpel; Arthur Garon; Thierry Langer; Matthäus Willeit; Margot Ernst
Journal:  Br J Pharmacol       Date:  2022-03-07       Impact factor: 9.473

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.